Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




STEHM to Use Electron Beam and Holography

By LabMedica International staff writers
Posted on 21 Jul 2009
A scanning transmission electron holography microscope (STEHM) will use an electron beam and holography techniques to observe the inside of materials and their surfaces to an expected resolution of one-fiftieth the size of an atom.

The difference between the STEHM technology and existing electron microscopes is that the latter only allow scientists to view materials in 50- to 90-nanometer-thin sections. More...
That means materials usually have to be cut apart in sections to be viewed. STEHM technology will allow scientists to see up to 500 nanometers at once.

Hitachi High-Technologies (Tokyo, Japan) is building the microscope in Japan. When installed in late 2010, it will occupy a specially adapted room of its own in one of the University of Victoria's (UVic; Victoria, BC, Canada) science buildings. It is expected to be operational by early 2011.

"This joint project will become the focal point for new discoveries at the atomic level and provide a platform for innovation for many years. We hope that this project will herald a new era of joint development and innovation between the University of Victoria and our company, and between Canada and Japan," said John S. Wilding Cole, president of Hitachi High-Technologies Canada.

The microscope is also able to observe the inside of materials as well as the outside. "Other scanning electron microscopes at the moment only look at surfaces of things," explained Dr. Elaine Humphrey, STEHM lab manager at UVic. She anticipates the microscope will be helpful in a range of fields, "from nuclear physics to fuel cells to microbiology to oceanography." Looking at the insides of brain cells, for example, will help medical professionals discover more about the debilitating disease, multiple sclerosis.

Related Links:

Hitachi High-Technologies
University of Victoria




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.